COVID-19 and the Response to Antiplatelet Therapy

The coronavirus SARS-CoV2 disease (COVID-19) is connected with significant morbidity and mortality (3.4%), disorders in hemostasis, including coagulopathy, activation of platelets, vascular injury, and changes in fibrinolysis, which may be responsible for an increased risk of thromboembolism. Many s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolek, Tomáš, Samoš, Matej, Jurica, Jakub, Stančiaková, Lucia, Péč, Martin Jozef, Škorňová, Ingrid, Galajda, Peter, Staško, Ján, Mokáň, Marián, Kubisz, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004309/
https://www.ncbi.nlm.nih.gov/pubmed/36902825
http://dx.doi.org/10.3390/jcm12052038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004309/
https://www.ncbi.nlm.nih.gov/pubmed/36902825
http://dx.doi.org/10.3390/jcm12052038

Ejemplares similares